Intravenous Immunoglobulin in Autoimmune Neuromuscular Diseases
JAMA 291:2367-2375, Dalakas,M.C., 2004
Subarachnoid Hemorrhage
NEJM 377:257-266, Lawton, M.T. & Vates, G.E., 2017
Practice Guideline Update Summary: Botulinum Neurotoxin for the Treatment of Blepharospasm, Cervical Dystonia, Adult Spasticity, and Headache
Neurol 86:1818-1826, Simpson, D.M.,et al, 2016
Myasthenia Gravis
NEJM 375:2570-2581, Gilhus, N.E.,et al, 2016
Palliative and End-Of-Life Care in Stroke
Stroke 45:1887-1916, Holloway, R.G.,et al, 2014
Early Surgical Therapy for Drug-Resistant Temporal Lobe Epilepsy
JAMA 307:922-930, Engel, J.,et al, 2012
Responding to Requests from Adult Patients for Neuroenhancements
Neurol 73:1406-1412, Larriviere,D.,et al, 2009
Practice Parameter Update: The Care of the Patient with Amyotrophic Lateral Sclerosis: Drug, Nutritional, and Respiratory Therapies (An Evidence-Based Review)
Neurol 73:1218-1226, Miller,R.G.,et al, 2009
Best Practice Recommendations for the Selection and Management of Patients with Multiple Sclerosis Receiving Natalizumab Therapy
Mutliple Sclerosis 15:S26-S36, Coyle,P.K.,et al, 2009
Spinal Cord Compression in Patients With Advanced Metastatic Cancer
JAMA 299:937-946, Abrahm,J.L.,et al, 2008
Pharmaceutical Interventions for Emotionalism After Stroke
Stroke 35:2610-2611, Horrocks,J.A.,et al, 2004
Practice Parameter:The Care of the Patient with Amyotrophic Lateral Sclerosis (An Evidence-Based Review), Report of the Quality Standards Subcommittee of the AAN
Neurol 52:1311-1323, Miller,R.G.,et al, 1999
Tube Feeding in Patients with Advanced Dementia,A Review of the Evidence
JAMA 282:1365-1370, Finucane,T.E.,et al, 1999
Management of Patients Receiving Interferon Beta-1b for MS:Report of a Consensus Conf
Neurol 46:12-18, Lublin,F.D.,et al, 1996
Pathogenesis of Obstructive Sleep Apnoea/Hypopnoea Syndrome
Lancet 344:653-655, Douglas,N.J.&Polo,O., 1994
The Sleep Apnoea/Hypopnoea Syndrome and Snoring
BMJ 306:1057-1060, Douglas,N.J., 1993